Search clinical trials for: Lenvatinib Pill

Total 3146 results

Shanghai Public Health Clinical Center
Fudan University; Shanghai Xinhao Biological Technology Co., Ltd.

Unknown

Euphorbia Kansui and HIV/AIDS Functional Cure

HIV-1-infection

China
New York Institute of Technology

Completed

The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease

Blood Pressure

United States
New York Institute of Technology
Michael J. Fox Foundation for Parkinson's Research

Completed

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Parkinson's Disease

United States
Umeå University
Glaukos Corporation

Completed

Advanced Cross Linking for Low-grade Myopia (PiXLO2)

Myopia | Corneal Crosslinking

Sweden
University of Puerto Rico
Merck Sharp & Dohme LLC

Terminated

Alvimopan Use in Polytraumatized Patients

Post Operative Ileus

Puerto Rico
Washington University School of Medicine
Barnes-Jewish Hospital; Orthopedic Research and Education Foundation

Completed

Alvimopan and Ileus in PSF

Ileus | Spinal Fusion

United States
Taizhou Fourth People's Hospital
Shanghai 10th People's Hospital

Unknown

The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris (DOLPHIN)

Inflammation | Angina, Stable

China
Dongzhimen Hospital, Beijing

Not yet recruiting

Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke (TREASURE)

Ischemic Stroke

China
Asan Medical Center
Chonnam National University Hospital; Ulsan University Hospital; Seoul National... and other collaborators

Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Korea, Republic of
Sun Yat-sen University

Recruiting

TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC (TACE)

Advanced Hepatocellular Carcinoma

China
Eisai Co., Ltd.

Completed

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Differentiated Thyroid Cancer (DTC)

China
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 (ACC-LEN14)

Adenoid Cystic Carcinomas of the Salivary Glands

Italy
Eisai Inc.

Completed

Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung

KIF5B-RET-Positive Adenocarcinoma of the Lung

United States, Hong Kong, Japan, Taiwan, Singapore
Eisai Inc.

Approved for marketing

An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

United States
Eisai Inc.

Completed

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

Metastatic Melanoma

United States
Eisai Inc.

Completed

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Renal Impairment | Disease Severity

United States
University of Florida

Completed

Detecting Lung Infections Through Vibration

Lung Infection

United States
Taipei Medical University WanFang Hospital
National Science Council, Taiwan

Unknown

Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients

Obesity | Schizophrenia | Metabolic Syndrome

Taiwan
Tianjin Medical University Cancer Institute and...

Recruiting

Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients

First-line Treatment | Advanced Gastric Carcinoma

China
Peking University Cancer Hospital & Institute

Completed

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

HCC

China
Eisai Co., Ltd.

Completed

A Study of E7080 in Subjects With Solid Tumor

Cancer

Japan
Eisai Inc.

Completed

An Open Label Dose Escalation Study Of E7080

Solid Tumor or Lymphoma

United Kingdom, Netherlands
Zhejiang Cancer Hospital

Unknown

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Carcinoma, Hepatocellular
Sun Yat-sen University

Withdrawn

Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Hepatocellular Carcinoma

China
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Fudan University

Recruiting

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Akeso

Recruiting

A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC

Unresectable, Non-metastatic Hepatocellular Carcinoma

China
Akeso
Akeso Pharmaceuticals, Inc.

Completed

A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Massachusetts General Hospital

Withdrawn

A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

Keratosis | Keratosis, Actinic | Skin Neoplasms
Boston Children's Hospital
GlaxoSmithKline

Terminated

Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

Hypertriglyceridemia

United States
University of Guelph
McMaster University; Medical University of Bialystok

Unknown

The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism

Skeletal Muscle Energy Metabolism

Canada
Shandong Public Health Clinical Center
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Not yet recruiting

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer
Merck Sharp & Dohme LLC

Active, not recruiting

Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Investigational Agents for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

Small Cell Lung Carcinoma

Poland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
University of Colorado, Boulder

Unknown

Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function

Vascular Aging

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

Breast Cancer | Hyposexual Desire Disorder

United States
Augusta University
National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences

Completed

The Role of Endothelin-1 in Sickle Cell Disease

Sickle Cell Anemia

United States
St. Joseph's Healthcare Hamilton

Unknown

Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm

Hemifacial Spasm | Blepharospasm

Canada
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

HIV/AIDS | Adherence, Medication

United States
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Automated Hovering for Congestive Heart Failure Patients (EMPOWER)

Heart Failure

United States
University of Mary Hardin-Baylor

Completed

The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

Blood Flow Restriction | Growth Hormone | Arginine | Strength Outcomes

United States
Medical College of Wisconsin
Merck Sharp & Dohme LLC

Terminated

Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair

Ventral Hernia

United States
Nova Scotia Health Authority
Dalhousie University; Capital Health, Canada

Terminated

Effects of Oral Iron on Postoperative Fatigue Upon Coronary Artery Bypass Graft Patients

Fatigue

Canada
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

Sensoril(Ashwaganhda)for Bipolar Disorder

Bipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOS

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Withdrawn

RTI-336 as a Treatment for Methamphetamine Dependence

Substance Abuse | Methamphetamine Dependence | Methamphetamine Abuse
Eisai Inc.

Completed

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Endometrial Cancer

United States, Poland, Ukraine, Bulgaria, Romania, Belgium, Russian Federation, Hungary
Zhejiang University

Completed

Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients (CISLD-12)

Advanced Hepatocellular Carcinoma

China
Eisai Co., Ltd.

Completed

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Neoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Carcinoma, Hepatocellular

Japan
Jinyang Gu

Completed

Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation

Hepatocellular Carcinoma

China
Eisai Inc.

Completed

Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers

Healthy Volunteers

United States

Search clinical trials for: Lenvatinib Pill

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations